References
- Cheraghlou S, Cohen JM. Early adoption of dupilumab in the medicare population in 2017. Yale J Biol Med. 2020;93(5):675–677.
- Feng H, Cohen JM, Neimann AL. Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers. J Dermatolog Treat. 2019;30(3):237–239.
- Wu KK, Nguyen KB, Sandhu JK, et al. Does location matter? Geographic variations in healthcare resource use for atopic dermatitis in the United States. J Dermatolog Treat. 2021;32(3):314–320.
- Centers for medicare and medicaid services medicare provider utilization and payment data: part D prescriber. 2020. [cited 2021 June 24]. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Part-D-Prescriber